Comparative study of proteome between primary cancer and hepatic metastatic tumor in colorectal cancer

被引:23
|
作者
Yu, Bo [1 ]
Li, Shi-Yong [1 ]
An, Ping [1 ]
Zhang, Ying-Nan [1 ]
Liang, Zhen-Jia [1 ]
Yuan, Shu-Jun [1 ]
Cai, Hui-Yun [1 ]
机构
[1] Beijing Mil Command, Gen Hosp, Dept Gen Surg, Beijing 100700, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.3748/wjg.v10.i18.2652
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To identify the differential proteins associated with colorectal cancer genesis and hepatic metastasis. METHODS: Hydrophobic protein samples were extracted from normal colorectal mucosa, primary cancer lesion and hepatic metastatic foci of colorectal cancer. With two-dimensional electrophoresis and image analysis, differentially expressed protein spots were detected, and the proteins were identified by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and peptide mass fingerprint analysis. RESULTS: Significant alterations of the proteins in number and expression levels were discovered in primary cancer and hepatic metastatic foci, the expression of a number of proteins was lost in 25-40 ku, but protein spots was increased in 14-21ku, compared with normal mucosa. Nine differentially expressed protein spots were identified. Three proteins expressed in normal mucosa, but lost in primary cancer and hepatic metastasis, were recognized as calmodulin, ribonuclease 6 precursor and mannosidase-a. Proapolipoprotein was expressed progressively from normal mucosa to primary cancer and hepatic metastasis. The differentially expressed protein of beta-globin was found in normal mucosa and hepatic metastatic tumor, but lost in primary cancer lesion. Cdc 42, a GTP-binding protein, was identified in hepatic metastasis. The protein spots of C4 from primary cancer, M7 and M9 from hepatic metastasis had less homology with the proteins in database. CONCLUSION: Variations of hydrophobic protein expression in colorectal cancer initiation and hepatic metastasis are significant and can be observed with two-dimensional electrophoresis. The expression of calmodulin, ribonuclease 6 precursor and mannosidase-a is lost but the expression of proapolipoprotein is enhanced which is associated with colorectal cancer genesis and hepatic metastasis. Cdc 42 and beta-globin are expressed abnormally in hepatic metastasis. Protein C4, M7 and M9 may be associated with colorectal cancer genesis and hepatic metastasis.
引用
收藏
页码:2652 / 2656
页数:5
相关论文
共 50 条
  • [21] Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer
    Wonseok Shin
    Jeongseok Yun
    Kyudong Han
    Dong-Guk Park
    Genes & Genomics, 2023, 45 : 989 - 1001
  • [22] The Metastatic Profile of Colorectal Cancer: The Interplay Between the Location of Primary Tumor and KRAS Mutational Status
    Yong, Z.
    Tan, G.
    Teo, M.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S160 - S160
  • [23] Comparative Effectiveness of Bevacizumab versus Cetuximab in Metastatic Colorectal Cancer Patients without Primary Tumor Resection
    Su, Yi-Chia
    Wu, Chih-Chien
    Su, Chien-Chou
    Hsieh, Meng-Che
    Cheng, Ching-Lan
    Kao Yang, Yea-Huei
    CANCERS, 2022, 14 (09)
  • [24] Mapping the Spatial Proteome of Metastatic Cells in Colorectal Cancer
    Mendes, Marta
    Pelaez-Garcia, Alberto
    Lopez-Lucendo, Maria
    Bartolome, Ruben A.
    Calvino, Eva
    Barderas, Rodrigo
    Ignacio Casal, J.
    PROTEOMICS, 2017, 17 (19)
  • [25] Differences in Chemosensitivity between Primary and Metastatic Tumors in Colorectal Cancer
    Takebayashi, Katsushi
    Mekata, Eiji
    Sonoda, Hiromichi
    Shimizu, Tomoharu
    Shiomi, Hisanori
    Naka, Shigeyuki
    Endo, Yoshihiro
    Tani, Tohru
    PLOS ONE, 2013, 8 (08):
  • [26] Synchronous hepatocellular carcinoma or metastatic hepatic tumor with primary gastric cancer
    Chen, CN
    Lee, PH
    Lee, WJ
    Chang, KJ
    Chen, KM
    HEPATO-GASTROENTEROLOGY, 1998, 45 (20) : 492 - 495
  • [27] Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer
    Miyamoto, Yuji
    Watanabe, Masayuki
    Sakamoto, Yasuo
    Shigaki, Hironobu
    Murata, Asuka
    Sugihara, Hidetaka
    Etoh, Kojiro
    Ishimoto, Takatsugu
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Iwagami, Shiro
    Yoshida, Naoya
    Baba, Hideo
    SURGERY TODAY, 2014, 44 (12) : 2287 - 2292
  • [28] Systemic treatment and primary tumor location in patients with metastatic colorectal cancer
    Antoniou, Efstathios
    Andreatos, Nikolaos
    Margonis, Georgios A.
    Papalois, Apostolos
    Wang, Jaeyun
    Damaskos, Christos
    Garmpis, Nikolaos
    Buettner, Stefan
    Deshwar, Amar
    Pappas, Vasilios
    Weiss, Matthew J.
    Pawlik, Timothy M.
    Pikoulis, Emmanouel
    JOURNAL OF BUON, 2017, 22 (06): : 1447 - 1456
  • [29] Impact of Primary Tumor Localization on the Efficacy of Bevacizumab in Metastatic Colorectal Cancer
    Jordan, Frank
    Grundmann, Nina
    Schenkirsch, Gerhard
    Maerkl, Bruno
    Messmann, Helmuth
    Anthuber, Matthias
    Schmid, Christoph
    Trepel, Martin
    ANTICANCER RESEARCH, 2018, 38 (09) : 5539 - 5546
  • [30] Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer
    Wong, Hui-li
    Lee, Belinda
    Field, Kathryn
    Lomax, Anna
    Tacey, Mark
    Shapiro, Jeremy
    McKendrick, Joe
    Zimet, Allan
    Yip, Desmond
    Nott, Louise
    Jennens, Ross
    Richardson, Gary
    Tie, Jeanne
    Kosmider, Suzanne
    Parente, Phillip
    Lim, Lionel
    Cooray, Prasad
    Ben Tran
    Desai, Jayesh
    Wong, Rachel
    Gibbs, Peter
    CLINICAL COLORECTAL CANCER, 2016, 15 (02) : E9 - E15